Real-World Outcomes in Patients with Transformed Follicular Lymphoma Treated with CD19-Targeting CAR-T Therapy

被引：0

作者：

Rivas-Delgado, Alfredo ^{[1
]}

Luttwak, Efrat ^{[1
]}

Drill, Esther ^{[2
]}

Goldstein, Ilan ^{[3
]}

Landego, Ivan ^{[3
,4
]}

Tomas, Ana Alarcon ^{[3
]}

Parascondola, Allison ^{[3
]}

Saldia, Amethyst ^{[3
]}

Caron, Philip ^{[1
]}

Dahi, Parastoo B. ^{[3
,4
]}

Epstein-Peterson, Zachary D. ^{[1
]}

Falchi, Lorenzo ^{[1
]}

Hamlin, Paul A. ^{[1
]}

Johnson, William ^{[1
,4
]}

Kumar, Anita ^{[5
]}

Lin, Richard J. ^{[3
,4
]}

Lue, Jennifer Kimberly ^{[1
]}

Owens, Colette ^{[1
]}

Noy, Ariela ^{[1
]}

Scordo, Michael ^{[3
,4
]}

Dogan, Ahmet ^{[6
]}

Seshan, Venkatraman ^{[2
]}

Zelenetz, Andrew D. ^{[1
]}

Perales, Miguel-Angel ^{[3
,4
]}

Shouval, Roni ^{[3
,4
]}

Palomba, Maria Lia ^{[1
,4
]}

Shah, Gunjan L. ^{[3
,4
]}

Salles, Gilles ^{[1
,4
]}

机构：

[1] Mem Sloan Kettering Canc Ctr, Dept Med, Lymphoma Serv, Barcelona, Spain

[2] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, New York, NY USA

[3] Mem Sloan Kettering Canc Ctr, Dept Med, Adult Bone Marrow Transplant Serv, New York, NY USA

[4] Mem Sloan Kettering Canc Ctr, Dept Med, Cellular Therapy Serv, New York, NY USA

[5] Mem Sloan Kettering Canc Ctr, New York, NY USA

[6] Mem Sloan Kettering Canc Ctr, Hematopathol Serv, Dept Pathol & Lab Med, New York, NY USA

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-187379

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：5

共 50 条

[11] Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Zheng, Na
Long, Yihao
Bai, Zixuan
Li, Jianing
Wang, Hongyu
Song, Dan-Dan
Liu, Hong-Lin
Shi, Jian-Hong
Zhao, Shuli
JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
[12] Melatonin as an immunomodulator in CD19-targeting CAR-T cell therapy: managing cytokine release syndrome
Na Zheng
Yihao Long
Zixuan Bai
Jianing Li
Hongyu Wang
Dan-Dan Song
Hong-Lin Liu
Jian-Hong Shi
Shuli Zhao
Journal of Translational Medicine, 22
[13] Significant response of patients with transformed follicular lymphoma with rapid disease progression to CAR-T therapy
Hirano, Taichi
Tatetsu, Hiro
Ueno, Shikiko
Shichijo, Takafumi
Furukawa, Shota
Tsujihashi, Mizuho
Miyakawa, Toshikazu
Shiraishi, Shinya
Higuchi, Yusuke
Uchiba, Mitsuhiro
Yasunaga, Jun-ichirou
Nosaka, Kisato
Matsuoka, Masao
JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2023, 63 (04) : 266 - 269
[14] CD19-Targeting CAR T-Cell Therapy in Transformed Waldenstrom Macroglobulinemia/Lymphoplasmacytic Lymphoma: A Descar-T and US Collaborative Study
Durot, Eric
Roos-Weil, Damien
Chauchet, Adrien
Decroocq, Justine
Di Blasi, Roberta
Gastinne, Thomas
Bensader, Hedi
Cheminant, Morgane
Jacquet, Caroline
Guidez, Stephanie
Gros, Francois-Xavier
Bachy, Emmanuel
Cony-Makhoul, Pascale
Treon, Steven P.
Delmer, Alain Jacques
Reshef, Ran
Le Gouill, Steven
Castillo, Jorge J.
Houot, Roch
BLOOD, 2023, 142
[15] An innovative in vivo model for CAR-T cell therapy development: Tolerability and efficacy evaluation of CD19-targeting CAR-T cells on human lymphoma using the chicken CAM assay
Wang, Yan
Rousset, Xavier
Prunier, Chloe
Dosda, Emilien
Gutierrez-Guerrero, Alejandra
Abrial, Pauline
Menkova, Inna
Viallet, Jean
CANCER RESEARCH, 2024, 84 (06)
[16] Timing of CAR-T therapy in follicular lymphoma
Moustafa, Muhamad Alhaj
EXPERT REVIEW OF ANTICANCER THERAPY, 2023, 23 (04) : 347 - 349
[17] CD19-Targeting CAR T-Cell Therapy for Antisynthetase Syndrome
Lundberg, Ingrid E.
Galindo-Feria, Angeles S.
Horuluoglu, Begum
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 329 (24): : 2130 - 2131
[18] Race and insurance: real-world insights on CAR-T outcomes
Ahmed, Nausheen
Grover, Natalie S.
BLOOD ADVANCES, 2024, 8 (10) : 2589 - 2591
[19] CAR-T Therapy for the Treatment of Relapsed/Refractory CD19 Positive Large B Cell Lymphoma: Canadian Real-World Evidence
Tan, Xiu Xia Sherry
Maltez, Melissa
Mallick, Ranjeeta
Hamelin, Linda
McDiarmid, Sheryl
Kennah, Michael
Atkins, Harold
Kekre, Natasha K.
BLOOD, 2023, 142
[20] Real-world evidence (RWE) study of CAR-T agents in leukemia and lymphoma patients.
Lal, Lincy S.
Blauer-Peterson, Cori
Byfield, Stacey DaCosta
Malin, Jennifer
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

← 1 2 3 4 5 →